Ziprasidone-induced hyperprolactinemia
dc.authorid | Unal, Suheyla/0000-0003-3266-6256 | |
dc.authorid | Unal, Suheyla/0000-0003-3266-6256 | |
dc.authorid | Karlıdağ, Rifat/0000-0002-3650-0774 | |
dc.authorid | HAMURCU, HAYRIYE DILEK/0000-0002-1456-2499 | |
dc.authorid | Selçuk, Engin Burak/0000-0001-8484-0223 | |
dc.authorwosid | karlıdağ, rıfat/AAB-4255-2021 | |
dc.authorwosid | Unal, Suheyla/JVO-8367-2024 | |
dc.authorwosid | Unal, Suheyla/HJH-7559-2023 | |
dc.authorwosid | Karlıdağ, Rifat/AAB-4281-2021 | |
dc.authorwosid | HAMURCU, HAYRIYE DILEK/W-2621-2017 | |
dc.authorwosid | Selçuk, Engin Burak/AAR-7556-2020 | |
dc.contributor.author | Citil, Dilek Yalvac | |
dc.contributor.author | Selcuk, Engin | |
dc.contributor.author | Karlidag, Rifat | |
dc.contributor.author | Unal, Sueheyla | |
dc.date.accessioned | 2024-08-04T20:30:42Z | |
dc.date.available | 2024-08-04T20:30:42Z | |
dc.date.issued | 2008 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | [Abstract Not Available] | en_US |
dc.identifier.doi | 10.1016/j.pnpbp.2007.12.022 | |
dc.identifier.endpage | 906 | en_US |
dc.identifier.issn | 0278-5846 | |
dc.identifier.issn | 1878-4216 | |
dc.identifier.issue | 3 | en_US |
dc.identifier.pmid | 18276052 | en_US |
dc.identifier.scopus | 2-s2.0-39849104813 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 905 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.pnpbp.2007.12.022 | |
dc.identifier.uri | https://hdl.handle.net/11616/94469 | |
dc.identifier.volume | 32 | en_US |
dc.identifier.wos | WOS:000254690300048 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Pergamon-Elsevier Science Ltd | en_US |
dc.relation.ispartof | Progress in Neuro-Psychopharmacology & Biological Psychiatry | en_US |
dc.relation.publicationcategory | Diğer | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Induced Galactorrhea | en_US |
dc.subject | Prolactin Levels | en_US |
dc.subject | Schizophrenia | en_US |
dc.subject | Antipsychotics | en_US |
dc.subject | Mechanism | en_US |
dc.title | Ziprasidone-induced hyperprolactinemia | en_US |
dc.type | Letter | en_US |